 | • レポートコード：MRC2-11QY04220 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は末梢動脈疾患（PAD）薬のグローバル市場について調査・分析したレポートです。種類別（クロピドグレル（プラビックス）、プラスグレル（効率的）、チカグレロル（ブリリンタ）、ボラパクサー（帯状）、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別末梢動脈疾患（PAD）薬の競争状況、市場シェア ・世界の末梢動脈疾患（PAD）薬市場：種類別市場規模 2015年-2020年（クロピドグレル（プラビックス）、プラスグレル（効率的）、チカグレロル（ブリリンタ）、ボラパクサー（帯状）、その他） ・世界の末梢動脈疾患（PAD）薬市場：種類別市場規模予測 2021年-2026年（クロピドグレル（プラビックス）、プラスグレル（効率的）、チカグレロル（ブリリンタ）、ボラパクサー（帯状）、その他） ・世界の末梢動脈疾患（PAD）薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の末梢動脈疾患（PAD）薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の末梢動脈疾患（PAD）薬市場分析：米国、カナダ ・ヨーロッパの末梢動脈疾患（PAD）薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの末梢動脈疾患（PAD）薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の末梢動脈疾患（PAD）薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの末梢動脈疾患（PAD）薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca Plc. (UK)、Bayer HealthCare Pharmaceuticals (Germany)、Bristol-Myers Squibb Company (US)、Merck & Co., Inc. (US)、Proteon Therapeutics, Inc. (US)、Sanofi S.A. (France)、Symic Bio, Inc. (US)、TheraVasc Inc. (US) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Peripheral Arterial Disease (PAD) Drugs Market
The global Peripheral Arterial Disease (PAD) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Peripheral Arterial Disease (PAD) Drugs Scope and Market Size
Peripheral Arterial Disease (PAD) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peripheral Arterial Disease (PAD) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)
Market segment by Type, the product can be split into
Clopidogrel (Plavix)
Prasugrel (Effient)
Ticagrelor (Brilinta)
Vorapaxar (Zontivity)
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Peripheral Arterial Disease (PAD) Drugs Revenue
1.4 Market by Type
1.4.1 Global Peripheral Arterial Disease (PAD) Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Clopidogrel (Plavix)
1.4.3 Prasugrel (Effient)
1.4.4 Ticagrelor (Brilinta)
1.4.5 Vorapaxar (Zontivity)
1.4.6 Others
1.5 Market by Application
1.5.1 Global Peripheral Arterial Disease (PAD) Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Arterial Disease (PAD) Drugs Market Perspective (2015-2026)
2.2 Global Peripheral Arterial Disease (PAD) Drugs Growth Trends by Regions
2.2.1 Peripheral Arterial Disease (PAD) Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Peripheral Arterial Disease (PAD) Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Peripheral Arterial Disease (PAD) Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Peripheral Arterial Disease (PAD) Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Arterial Disease (PAD) Drugs Players by Market Size
3.1.1 Global Top Peripheral Arterial Disease (PAD) Drugs Players by Revenue (2015-2020)
3.1.2 Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Peripheral Arterial Disease (PAD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Peripheral Arterial Disease (PAD) Drugs Market Concentration Ratio
3.2.1 Global Peripheral Arterial Disease (PAD) Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Peripheral Arterial Disease (PAD) Drugs Revenue in 2019
3.3 Peripheral Arterial Disease (PAD) Drugs Key Players Head office and Area Served
3.4 Key Players Peripheral Arterial Disease (PAD) Drugs Product Solution and Service
3.5 Date of Enter into Peripheral Arterial Disease (PAD) Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Peripheral Arterial Disease (PAD) Drugs Historic Market Size by Type (2015-2020)
4.2 Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
5.2 Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2020)
6.2 Peripheral Arterial Disease (PAD) Drugs Key Players in North America (2019-2020)
6.3 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
6.4 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2020)
7.2 Peripheral Arterial Disease (PAD) Drugs Key Players in Europe (2019-2020)
7.3 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
7.4 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
8 China
8.1 China Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2020)
8.2 Peripheral Arterial Disease (PAD) Drugs Key Players in China (2019-2020)
8.3 China Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
8.4 China Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2020)
9.2 Peripheral Arterial Disease (PAD) Drugs Key Players in Japan (2019-2020)
9.3 Japan Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
9.4 Japan Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2020)
10.2 Peripheral Arterial Disease (PAD) Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
11 India
11.1 India Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2020)
11.2 Peripheral Arterial Disease (PAD) Drugs Key Players in India (2019-2020)
11.3 India Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
11.4 India Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2020)
12.2 Peripheral Arterial Disease (PAD) Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
12.4 Central & South America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AstraZeneca Plc. (UK)
13.1.1 AstraZeneca Plc. (UK) Company Details
13.1.2 AstraZeneca Plc. (UK) Business Overview
13.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Introduction
13.1.4 AstraZeneca Plc. (UK) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2015-2020))
13.1.5 AstraZeneca Plc. (UK) Recent Development
13.2 Bayer HealthCare Pharmaceuticals (Germany)
13.2.1 Bayer HealthCare Pharmaceuticals (Germany) Company Details
13.2.2 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
13.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Introduction
13.2.4 Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2015-2020)
13.2.5 Bayer HealthCare Pharmaceuticals (Germany) Recent Development
13.3 Bristol-Myers Squibb Company (US)
13.3.1 Bristol-Myers Squibb Company (US) Company Details
13.3.2 Bristol-Myers Squibb Company (US) Business Overview
13.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Introduction
13.3.4 Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2015-2020)
13.3.5 Bristol-Myers Squibb Company (US) Recent Development
13.4 Merck & Co., Inc. (US)
13.4.1 Merck & Co., Inc. (US) Company Details
13.4.2 Merck & Co., Inc. (US) Business Overview
13.4.3 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Drugs Introduction
13.4.4 Merck & Co., Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2015-2020)
13.4.5 Merck & Co., Inc. (US) Recent Development
13.5 Proteon Therapeutics, Inc. (US)
13.5.1 Proteon Therapeutics, Inc. (US) Company Details
13.5.2 Proteon Therapeutics, Inc. (US) Business Overview
13.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Introduction
13.5.4 Proteon Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2015-2020)
13.5.5 Proteon Therapeutics, Inc. (US) Recent Development
13.6 Sanofi S.A. (France)
13.6.1 Sanofi S.A. (France) Company Details
13.6.2 Sanofi S.A. (France) Business Overview
13.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Introduction
13.6.4 Sanofi S.A. (France) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2015-2020)
13.6.5 Sanofi S.A. (France) Recent Development
13.7 Symic Bio, Inc. (US)
13.7.1 Symic Bio, Inc. (US) Company Details
13.7.2 Symic Bio, Inc. (US) Business Overview
13.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Introduction
13.7.4 Symic Bio, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2015-2020)
13.7.5 Symic Bio, Inc. (US) Recent Development
13.8 TheraVasc Inc. (US)
13.8.1 TheraVasc Inc. (US) Company Details
13.8.2 TheraVasc Inc. (US) Business Overview
13.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Drugs Introduction
13.8.4 TheraVasc Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2015-2020)
13.8.5 TheraVasc Inc. (US) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Peripheral Arterial Disease (PAD) Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Peripheral Arterial Disease (PAD) Drugs Revenue
Table 3. Ranking of Global Top Peripheral Arterial Disease (PAD) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Peripheral Arterial Disease (PAD) Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Clopidogrel (Plavix)
Table 6. Key Players of Prasugrel (Effient)
Table 7. Key Players of Ticagrelor (Brilinta)
Table 8. Key Players of Vorapaxar (Zontivity)
Table 9. Key Players of Others
Table 10. Global Peripheral Arterial Disease (PAD) Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Regions (2015-2020)
Table 14. Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Peripheral Arterial Disease (PAD) Drugs Market Growth Strategy
Table 20. Main Points Interviewed from Key Peripheral Arterial Disease (PAD) Drugs Players
Table 21. Global Peripheral Arterial Disease (PAD) Drugs Revenue by Players (2015-2020) (Million US$)
Table 22. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Players (2015-2020)
Table 23. Global Top Peripheral Arterial Disease (PAD) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Arterial Disease (PAD) Drugs as of 2019)
Table 24. Global Peripheral Arterial Disease (PAD) Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Peripheral Arterial Disease (PAD) Drugs Product Solution and Service
Table 27. Date of Enter into Peripheral Arterial Disease (PAD) Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020) (Million US$)
Table 30. Global Peripheral Arterial Disease (PAD) Drugs Market Size Share by Type (2015-2020)
Table 31. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type (2021-2026)
Table 32. Global Peripheral Arterial Disease (PAD) Drugs Market Size Share by Application (2015-2020)
Table 33. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020) (Million US$)
Table 34. Global Peripheral Arterial Disease (PAD) Drugs Market Size Share by Application (2021-2026)
Table 35. North America Key Players Peripheral Arterial Disease (PAD) Drugs Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Peripheral Arterial Disease (PAD) Drugs Market Share (2019-2020)
Table 37. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020) (Million US$)
Table 38. North America Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2015-2020)
Table 39. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020) (Million US$)
Table 40. North America Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2015-2020)
Table 41. Europe Key Players Peripheral Arterial Disease (PAD) Drugs Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Peripheral Arterial Disease (PAD) Drugs Market Share (2019-2020)
Table 43. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2015-2020)
Table 45. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2015-2020)
Table 47. China Key Players Peripheral Arterial Disease (PAD) Drugs Revenue (2019-2020) (Million US$)
Table 48. China Key Players Peripheral Arterial Disease (PAD) Drugs Market Share (2019-2020)
Table 49. China Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020) (Million US$)
Table 50. China Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2015-2020)
Table 51. China Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020) (Million US$)
Table 52. China Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2015-2020)
Table 53. Japan Key Players Peripheral Arterial Disease (PAD) Drugs Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Peripheral Arterial Disease (PAD) Drugs Market Share (2019-2020)
Table 55. Japan Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2015-2020)
Table 57. Japan Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Peripheral Arterial Disease (PAD) Drugs Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Peripheral Arterial Disease (PAD) Drugs Market Share (2019-2020)
Table 61. Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2015-2020)
Table 63. Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2015-2020)
Table 65. India Key Players Peripheral Arterial Disease (PAD) Drugs Revenue (2019-2020) (Million US$)
Table 66. India Key Players Peripheral Arterial Disease (PAD) Drugs Market Share (2019-2020)
Table 67. India Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020) (Million US$)
Table 68. India Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2015-2020)
Table 69. India Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020) (Million US$)
Table 70. India Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Peripheral Arterial Disease (PAD) Drugs Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Peripheral Arterial Disease (PAD) Drugs Market Share (2019-2020)
Table 73. Central & South America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2015-2020)
Table 75. Central & South America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2015-2020)
Table 77. AstraZeneca Plc. (UK) Company Details
Table 78. AstraZeneca Plc. (UK) Business Overview
Table 79. AstraZeneca Plc. (UK) Product
Table 80. AstraZeneca Plc. (UK) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2015-2020) (Million US$)
Table 81. AstraZeneca Plc. (UK) Recent Development
Table 82. Bayer HealthCare Pharmaceuticals (Germany) Company Details
Table 83. Bayer HealthCare Pharmaceuticals (Germany) Business Overview
Table 84. Bayer HealthCare Pharmaceuticals (Germany) Product
Table 85. Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2015-2020) (Million US$)
Table 86. Bayer HealthCare Pharmaceuticals (Germany) Recent Development
Table 87. Bristol-Myers Squibb Company (US) Company Details
Table 88. Bristol-Myers Squibb Company (US) Business Overview
Table 89. Bristol-Myers Squibb Company (US) Product
Table 90. Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2015-2020) (Million US$)
Table 91. Bristol-Myers Squibb Company (US) Recent Development
Table 92. Merck & Co., Inc. (US) Company Details
Table 93. Merck & Co., Inc. (US) Business Overview
Table 94. Merck & Co., Inc. (US) Product
Table 95. Merck & Co., Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2015-2020) (Million US$)
Table 96. Merck & Co., Inc. (US) Recent Development
Table 97. Proteon Therapeutics, Inc. (US) Company Details
Table 98. Proteon Therapeutics, Inc. (US) Business Overview
Table 99. Proteon Therapeutics, Inc. (US) Product
Table 100. Proteon Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2015-2020) (Million US$)
Table 101. Proteon Therapeutics, Inc. (US) Recent Development
Table 102. Sanofi S.A. (France) Company Details
Table 103. Sanofi S.A. (France) Business Overview
Table 104. Sanofi S.A. (France) Product
Table 105. Sanofi S.A. (France) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2015-2020) (Million US$)
Table 106. Sanofi S.A. (France) Recent Development
Table 107. Symic Bio, Inc. (US) Company Details
Table 108. Symic Bio, Inc. (US) Business Overview
Table 109. Symic Bio, Inc. (US) Product
Table 110. Symic Bio, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2015-2020) (Million US$)
Table 111. Symic Bio, Inc. (US) Recent Development
Table 112. TheraVasc Inc. (US) Business Overview
Table 113. TheraVasc Inc. (US) Product
Table 114. TheraVasc Inc. (US) Company Details
Table 115. TheraVasc Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2015-2020) (Million US$)
Table 116. TheraVasc Inc. (US) Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Type: 2020 VS 2026
Figure 2. Clopidogrel (Plavix) Features
Figure 3. Prasugrel (Effient) Features
Figure 4. Ticagrelor (Brilinta) Features
Figure 5. Vorapaxar (Zontivity) Features
Figure 6. Others Features
Figure 7. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Peripheral Arterial Disease (PAD) Drugs Report Years Considered
Figure 12. Global Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Regions: 2020 VS 2026
Figure 14. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Players in 2019
Figure 17. Global Top Peripheral Arterial Disease (PAD) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Arterial Disease (PAD) Drugs as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Peripheral Arterial Disease (PAD) Drugs Revenue in 2019
Figure 19. North America Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
末梢動脈疾患（PAD）治療薬の世界市場（～2026年） Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. When narrowing occurs in the heart, it is called coronary artery disease, while, in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the…- 3D動脈スピンラベリング（3D ASL）の世界市場（～2026年） Market Analysis and Insights: Global 3D Arterial Spin Labeling (3D ASL) Market The global 3D Arterial Spin Labeling (3D ASL) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global 3D Arterial Spin Labeling (3D ASL) Scope and …
- クラッベ病治療薬の世界市場（～2026年） Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to mak…
- 重症筋無力症治療薬の世界市場（～2026年） Myasthenia gravis is a neuromuscular disorder that leads to the weakening of skeletal muscles, which are responsible for the movement of the body. This condition occurs due to the impairment of communication between muscles and nerve cells. This impairment causes difficulties in the contraction and …
- 肺動脈性肺高血圧症（PAH）の世界市場（～2026年） Market Analysis and Insights: Global Pulmonary Arterial Hypertension (PAH) Market The global Pulmonary Arterial Hypertension (PAH) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pulmonary Arterial Hypertension (PAH) S…